PKP3 and ovarian carcinoma: As the expression and regulatory mechanism of PKP3 in ovarian cancer has been confirmed by many researchers previously [13, 14], the expression and prognosis of PKP2 were further selected for validation with immunohistochemistry, which is helpful to provide a new strategy for early diagnosis and treatment of ovarian cancer.